» Articles » PMID: 34658948

Medical Comorbidities in 181 Patients With Bipolar Disorder . Schizophrenia and Related Psychotic Disorders: Findings From a Single-Center, Retrospective Study From an Acute Inpatients Psychiatric Unit

Overview
Specialty Psychiatry
Date 2021 Oct 18
PMID 34658948
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Medical comorbidities (MCs) represent a significant burden in terms of more frequent hospitalizations and overall lower life expectancy among people with severe mental disorders, such as schizophrenia and related psychotic disorders (SZ) and bipolar disorder (BD). The present article aims to compare the prevalence of MCs and to examine the associated characteristics as marital status, job occupation, level of education, and living arrangements, between BD and SZ patients. One-hundred-eight-one patients with MCs (85/47% had BD and 96/53% had SZ) were recruited retrospectively from the Acute Inpatients Psychiatry Unit of Policlinico Tor Vergata, Rome, between January-2017 and December-2020. MCs were: cardiovascular diseases (CVD), bacterial infections, mycoses, viral diseases, neoplasms, musculoskeletal, respiratory tract, urological and male genital, gynecological, neurological, gastrointestinal, metabolic syndrome, nutritional, and metabolic diseases. BD had more MC than SZ (36.2 vs. 28.2%, respectively, = 0.04). CVD and metabolic MC were more common among BD (51.8 vs.34.4%; 51.8 vs.35.3%; = 0.018; = 0.039; respectively), while viral diseases were more frequent in SZ (13.5 vs.3.5%, = 0.035). Hypertension was common in both psychiatric illnesses (81.8% BD vs. 65.6% SZ, = 0.18). Obesity was the most frequent metabolic disease in both BD and SZ (75% BD vs. 73.5% SZ, = 0.91), followed by diabetes mellitus (52.3% BD . 55.9% SZ, = 0.93), metabolic syndrome (54.5% BD vs. 47.1% SZ, = 0.67) and dysthyroidism (47.7% BD vs. 25.7% SZ, = 0.093). After performing a binary logistic regression analysis, only two MCs showed a statistically significant association: patients with SZ had an OR of 2.01 [CI 95% (1.00-4.01)] for CVD compared to BD; on the other hand, patients with BD had an OR of 16.57 [CI 95% (3.58-76.77)] for gynecological diseases compared to SZ patients. MCs are common among people with severe mental illness, especially CVD and metabolic diseases, highlighting the need for a more collaborative relationship between general medical providers and psychiatrists.

Citing Articles

Prediction of medical admissions after psychiatric inpatient hospitalization in bipolar disorder: a retrospective cohort study.

Miola A, De Prisco M, Lussignoli M, Meda N, Dughiero E, Costa R Front Psychiatry. 2024; 15:1435199.

PMID: 39290307 PMC: 11406175. DOI: 10.3389/fpsyt.2024.1435199.


Sex differences evident in elevated anxiety symptoms in multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis.

Joyees J, Marrie R, Bernstein C, Bolton J, Fisk J, Graff L Front Psychiatry. 2023; 14:1260420.

PMID: 38076706 PMC: 10702748. DOI: 10.3389/fpsyt.2023.1260420.


Relationship between clozapine exposure and the onset of appendicitis in schizophrenia patients: a retrospective cohort study.

Kawakita Y, Takeshima M, Komatsu T, Imanishi A, Fujiwara D, Itoh Y BMC Psychiatry. 2022; 22(1):653.

PMID: 36271340 PMC: 9587653. DOI: 10.1186/s12888-022-04312-4.


Psychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of Research.

Damba J, Bodenstein K, Lavin P, Drury J, Sekhon H, Renoux C CNS Drugs. 2022; 36(10):1049-1077.

PMID: 36161425 DOI: 10.1007/s40263-022-00952-y.


Sexuality in Ultra-High Risk for Psychosis and First-Episode Psychosis. A Systematic Review of Literature.

Ciocca G, Jannini T, Ribolsi M, Rossi R, Niolu C, Siracusano A Front Psychiatry. 2021; 12:750033.

PMID: 34777053 PMC: 8579023. DOI: 10.3389/fpsyt.2021.750033.

References
1.
Carney C, Jones L, Woolson R . Medical comorbidity in women and men with schizophrenia: a population-based controlled study. J Gen Intern Med. 2006; 21(11):1133-7. PMC: 1831667. DOI: 10.1111/j.1525-1497.2006.00563.x. View

2.
Owens S, Purves-Tyson T, Webster M, Weickert C . Evidence for enhanced androgen action in the prefrontal cortex of people with bipolar disorder but not schizophrenia or major depressive disorder. Psychiatry Res. 2019; 280:112503. DOI: 10.1016/j.psychres.2019.112503. View

3.
Martin D, Ul-Haq Z, Nicholl B, Cullen B, Evans J, Gill J . Cardiometabolic disease and features of depression and bipolar disorder: population-based, cross-sectional study. Br J Psychiatry. 2016; 208(4):343-51. DOI: 10.1192/bjp.bp.114.157784. View

4.
Weber N, Fisher J, Cowan D, Niebuhr D . Psychiatric and general medical conditions comorbid with bipolar disorder in the National Hospital Discharge Survey. Psychiatr Serv. 2011; 62(10):1152-8. DOI: 10.1176/ps.62.10.pss6210_1152. View

5.
Vergara-Rodriguez P, Vibhakar S, Watts J . Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness. Pharmacol Ther. 2009; 124(3):269-78. DOI: 10.1016/j.pharmthera.2009.07.004. View